300+ investors in your industry, stage, and region Get
Any industry
Artificial Intelligence
Google
EdTech
Clean Energy
Retail
Enterprise Software
Local
Travel
Platforms
InsurTech
Oil and Gas
Social Impact
Cryptocurrency
SaaS
Film
Restaurants
Photography
Payments
Renewable Energy
Organic Food
Email
Fitness
CleanTech
Energy
Health Care
Machine Learning
Agriculture (AgTech)
Marketplace
Gaming
Blockchain
Facebook
B2B
Social Network
Big Data
Video Games
Education
Wellness
Medical Device
Mobile
Legal
Sports
Construction
Automotive
eSports
Hospitality
Biotechnology
Consumer
Software
Crowdfunding
Venture Capital
Social
Infrastructure
Fashion
Beauty
LGBT
Celebrity
Cannabis
Climate
Mobile Apps
Life Science
Publishing
Food and Beverage
Wine and Spirits
Real Estate
Sporting Goods
Art
Music
Finance
Digital Media
FinTech
Manufacturing
Social Media
Financial Services
Franchise
Non Profit
Mobile Advertising
Internet
Android
Impact
Biotech
Proptech
Sustainability
Hardware
Transportation
Enterprise
Community
Media (Entertainment)
Web3
Medical
Theatre
Recruiting
Any country
South Korea
Africa
Oceania
Brazil
Saudi Arabia
Singapore
LATAM
Greece
Gibraltar
Norway
Liberia
Mexico
Taiwan
Sweden
Zambia
Puerto Rico
Tunisia
Russian Federation
Togo
Tajikistan
Nigeria
Isle of Man
Pakistan
Zimbabwe
Colombia
Romania
Oman
Cameroon
Australia
India
New Zealand
China
Sri Lanka
Vietnam
Armenia
Costa Rica
Chile
Switzerland
Czech Republic
Cayman Islands
Kenya
Kuwait
Kazakhstan
Jamaica
Marshall Islands
Luxembourg
Malta
Namibia
Mozambique
Mauritius
Nicaragua
Panama
Serbia
Uganda
Turkey
Uzbekistan
Venezuela
Guatemala
Seychelles
Japan
Germany
United Kingdom
Canada
Ireland
South Africa
Egypt
France
Georgia
Denmark
Croatia
Hong Kong
Ghana
Iraq
Mali
Morocco
Myanmar
Latvia
Malaysia
Portugal
Philippines
Poland
Rwanda
Sierra Leone
Senegal
Thailand
El Salvador
Uruguay
Tanzania
United States
Indonesia
Middle East
Bermuda
Dominican Republic
Asia
Albania
Cyprus
Qatar
United Arab Emirates
Spain
Angola
Europe
Argentina
Bangladesh
Barbados
Belgium
Austria
Ethiopia
Jordan
Azerbaijan
Bulgaria
Ecuador
Bahrain
Bahamas
Estonia
Faroe Islands
Jersey
Bolivia
Belize
Algeria
Belarus
Finland
Italy
Hungary
Grenada
Israel
Honduras
Iceland
Cambodia
Lithuania
Liechtenstein
Lebanon
Mongolia
Peru
Slovenia
San Marino
Ukraine
Angel Investors
VC Funds
All Investors
Download Find emails Save list
Open database

Top 50 Biotech VC Funds & Investors in Austria (June 2026)

The most active venture capital funds investing in Austria Biotech startups. This investor list is updated monthly from the Shizune investor database, ranked by number of investments in Austria Biotech startup companies. Find investors to raise a Pre-Seed, Seed or Series A round with Shizune.
Investor Relevant Deals Geography Stage Focus Round Size
XISTA Science Ventures
VC Fund
12 Austria, France, Slovenia Seed, Pre-Seed, Series A Biotechnology, Medical, Software $511k–$20M
xista science ventures
VC Fund
9 Austria, Slovenia Seed, Pre-Seed, Series A Biotechnology, Medical, Software $511k–$20M
tecnet equity
VC Fund
7 Austria Seed, Series A Software, SaaS, Biotechnology $400k–$6M
SOSV
VC Fund
5 United States, India, United Kingdom Seed, Convertible Note, Pre-Seed Biotechnology, Health Care, Software
austria Wirtschaftsservice (aws)
VC Fund
5 Austria, Belgium Seed, Grant, Pre-Seed Software, SaaS, Information Technology $44k–$2.7M
MIG Capital
VC Fund
4 Germany, France, Austria Series A, Series B Biotechnology, Health Care, Therapeutics $1.6M–$54M
aws Gründungsfonds
VC Fund
3 Austria, Germany, United States Seed, Series A Software, SaaS, Information Technology $1.1M–$12M
10x Founders
VC Fund
2 Germany, United States, Switzerland Seed, Series A, Pre-Seed Software, Information Technology, Artificial Intelligence $1.1M–$60M
VP Venture Partners
VC Fund
2 Austria, Switzerland Seed Medical, Health Diagnostics, Internet $3M–$3.3M
bmp Ventures
VC Fund
2 Germany, United States, Austria Seed, Series A Software, Information Technology, Manufacturing $30k–$5.9M
Longevitytech.fund
VC Fund
2 United States, United Kingdom, The Netherlands Seed, Convertible Note, Pre-Seed Biotechnology, Health Care, Life Science $100k–$10M
Gamma Capital Partners
VC Fund
2 Austria, United States, Germany Series A, Seed Software, Manufacturing, Information Technology $406k–$8M
Arax Capital Partners
VC Fund
2 Austria Seed Biotechnology, Health Care, Medical
APEX Ventures
VC Fund
2 Germany, United Kingdom, Austria Seed, Series A, Pre-Seed Artificial Intelligence, Software, Health Care $511k–$21M
R42 Group
VC Fund
2 United Kingdom, United States, Austria Seed, Pre-Seed Biotechnology, Health Care, Software $439k–$8M
Aescap Venture
VC Fund
2 United Kingdom, Austria, Belgium Series A, Series B Biotechnology, Pharmaceutical, Chemical $1.5M–$33M
Übermorgen Ventures
VC Fund
2 Germany, Switzerland, Finland Seed, Pre-Seed, Series A Software, Energy, Renewable Energy $344k–$12M
Lansdowne Partners
VC Fund
2 United Kingdom, Austria, United States Series A, Series B Biotechnology, Finance, Genetics $6.8M–$100M
TSVC
VC Fund
2 United States, China, Canada Seed, Series A Software, Artificial Intelligence, Health Care $500k–$27M
BackBone Ventures
VC Fund
2 Switzerland, Germany, Israel Pre-Seed, Seed, Series A Artificial Intelligence, Information Technology, Software $583k–$105M
Nina Capital
VC Fund
2 United States, United Kingdom, Germany Seed, Pre-Seed, Series A Health Care, Artificial Intelligence, Software $573k–$22M
eQventure
VC Fund
2 Austria, Switzerland Seed, Series A Software, Information Technology, Artificial Intelligence $549k–$6.6M
red-stars.com
VC Fund
2 Austria, Germany Seed, Series A Software, Biotechnology, Telecommunications $1.6M–$4.4M
The Austrian Research Promotion Agency (FFG)
VC Fund
2 Austria, United States, Belgium Grant, Seed, Pre-Seed Software, Artificial Intelligence, Medical $67k–$3.5M
PUSH VC
VC Fund
2 Austria, Germany, United States Seed, Series A Software, Apps, Health Care $650k–$32M
FPS-Holding
VC Fund
2 Austria Seed Biotechnology, Health Diagnostics $420k–$429k
HackCapital
VC Fund
1 United States, Israel, United Kingdom Seed, Pre-Seed, Series A Biotechnology, Food and Beverage, Food Processing
IBG Beteiligungsgesellschaft Sachsen-Anhalt
VC Fund
1 Germany, Austria Seed, Series A Electronics, Software, Medical Device
Santo Holding
VC Fund
1 Germany, Austria Series B, Series C Biotechnology, Energy, Medical
Clima Now
VC Fund
1 Switzerland, Germany, Austria Seed, Grant, Pre-Seed Farming, Renewable Energy, Solar
Lansdowne Investment Company Cyprus
VC Fund
1 Austria Seed Life Science, Biotechnology, Semiconductor
Axilium Holding
VC Fund
1 Austria Seed Life Science, Biotechnology, Semiconductor
Valnon Holding
VC Fund
1 Austria Seed Biotechnology, Chemical Engineering
RKP InnoInvest
VC Fund
1 Austria Seed Biotechnology, Food and Beverage
EMBL Ventures
VC Fund
1 Germany, Austria, Ireland Series A, Series B, Series C Biotechnology, Health Care, Therapeutics $3.9M–$70M
EIT Health
VC Fund
1 United Kingdom, Spain, Ireland Grant, Pre-Seed, Seed Health Care, Medical Device, Medical $22k–$1.6M
HBM Partners
VC Fund
1 United States, Germany, Switzerland Series B, Series C Biotechnology, Medical, Health Care $2.5M–$125M
FastVentures
VC Fund
1 Hungary, South Korea, United States Seed, Series A, Series B Software, Biotechnology, Information Technology $424k–$31M
Wellcome Trust
VC Fund
1 United States, United Kingdom, France Grant, Series C Biotechnology, Health Care, Medical $1.3M–$127M
Possible Ventures
VC Fund
1 Germany, Australia, United States Seed, Pre-Seed, Series A Software, Biotechnology, Information Technology $549k–$44M
Synthesis Capital
VC Fund
1 United States, Israel, Austria Seed, Series A, Series C Biotechnology, Food and Beverage, Organic Food $7.1M–$23M
GLS Ventures
VC Fund
1 Austria Series B Medical, Health Care, Biotechnology
FCPG Affi
VC Fund
1 Austria Medical, Biotechnology, Pharmaceutical
OrbiMed
VC Fund
1 United States, China, Israel Series B, Series A, Series C Biotechnology, Health Care, Medical $10M–$150M
Andera Partners
VC Fund
1 France, United States, Germany Series B, Private Equity Biotechnology, Health Care, Medical $14M–$247M
Boehringer Ingelheim Venture Fund
VC Fund
1 United States, Germany, Switzerland Series A, Series B, Seed Biotechnology, Health Care, Therapeutics $1.3M–$50M
Amino Collective
VC Fund
1 United States, United Kingdom, Germany Seed, Series A, Pre-Seed Health Care, Biotechnology, Medical $125k–$37M
i&i Biotech Fund
VC Fund
1 Czech Republic, India, Spain Seed, Series A Biotechnology, Health Care, Medical
4SC
VC Fund
1 Austria Seed Health Care, Biotechnology
Forbion Capital Partners
VC Fund
1 United States, United Kingdom, The Netherlands Series B, Series A, Series C Biotechnology, Health Care, Medical $15M–$176M
Access all 153 VC funds in Austria Biotech startups.

Access 48,091 investors

822 industries, 177 countries. Updated daily. Emails and phones included.

Browse database — It's Free!

Investor list

XISTA Science Ventures
VC Fund · Klosterneuburg, Niederosterreich, Austria · 12 investments in Austria Biotech startups

We invest in deep tech startups and academic spin-offs with a strong innovation based on science, engineering and technology. We invest as lead investor in pre-seed and seed stages and have the ability to follow on in later rounds. We understand the needs of science and tech based startups and offer tailored support for entrepreneurs. We areembedded in the venture capital scene, yet understand the language of science and the world of research. Thanks to our diverse team, our expertise and experience in technology, entrepreneurship, finance, legal, IP, and strategic consulting will support your startup right from the start.

Show more...

Investment focus

  • Industry: Biotechnology, Medical, Software
  • Stage:Seed, Pre-Seed, Series A
  • Geography: Austria, France, Slovenia

Investor stats

  • Total investments: 33
  • Round size: Seed $576k–$5.9M; Pre-Seed $511k–$1.4M; Series A $5.2M–$20M
  • Lead/follow: 61% lead, 39% follow

Portfolio highlights

  • Rivus Batteries — Rivus is a start-up that serves as the commercialization platform for the aqueous organic flow battery technology.
  • Factorymaker — Factorymaker designs and analyzes sustainable, cost-efficient industrial layout and building proposals, guiding you through informed decisions at early design stage
  • VALANX Biotech — VALANX Biotech is a site-specific protein conjugation platform to enable fast and cost efficient protein-drug-conjugates development.
Show all investments...

xista science ventures
VC Fund · Klosterneuburg, Niederosterreich, Austria · 9 investments in Austria Biotech startups

We invest in deep tech startups and academic spin-offs with a strong innovation based on science, engineering and technology. We invest as lead investor in pre-seed and seed stages and have the ability to follow on in later rounds. We understand the needs of science and tech based startups and offer tailored support for entrepreneurs. We areembedded in the venture capital scene, yet understand the language of science and the world of research. Thanks to our diverse team, our expertise and experience in technology, entrepreneurship, finance, legal, IP, and strategic consulting will support your startup right from the start.

Show more...

Investment focus

  • Industry: Biotechnology, Medical, Software
  • Stage:Seed, Pre-Seed, Series A
  • Geography: Austria, Slovenia

Investor stats

  • Total investments: 22
  • Round size: Seed $1.8M–$7.8M; Pre-Seed $511k–$1.4M; Series A $5.2M–$20M
  • Lead/follow: 64% lead, 36% follow

Portfolio highlights

  • subdron — subdron turns the seabed from a blind spot into a monitored domain.
  • infrared.city — Redefine environmental simulations. Our bespoke AI models revolutionise performative design, slashing time, cost, and complexity. Access cutting-edge services effortlessly because innovation should be for everyone
  • VALANX Biotech — VALANX Biotech is a site-specific protein conjugation platform to enable fast and cost efficient protein-drug-conjugates development.
Show all investments...

tecnet equity
VC Fund · Sankt Polten, Niederosterreich, Austria · 7 investments in Austria Biotech startups

tecnet equity is an Austrian venture capital fund investing in innovative high-tech companies with potential for significant growth.

Show more...

Investment focus

  • Industry: Software, SaaS, Biotechnology
  • Stage:Seed, Series A
  • Geography: Austria

Investor stats

  • Total investments: 62
  • Round size: Seed $400k–$2.5M; Series A $583k–$6M
  • Lead/follow: 35% lead, 65% follow
  • Last fund: May invest from a new fund soon — last raise in 2009

Portfolio highlights

  • eyeson — eyeson is a leader in cloud-based video conferencing with managed multipoint video processing technology at a scale. Based on its patented single stream technology, eyeson provides API video services to easily integrate video collaboration in business workflows for full customer engagement. eyeson is managing the cloud capacity, scalable videocoding performance and data management for the customer. Based on WebRTC technology, eyeson provides browser-based video meeting integrations on all desktop and mobile devices. eyeson offers B2B focused products used by Forbes 500 companies and named by Gartner as "cool vendor in unified communications."
  • Sipfront — Sipfront helps telecom operators to deliver better services by automating 24/7 active monitoring and by providing a test framework to simulate customer calls at scale
  • Greenwood-Power — Greenwood-Power is the leading innovator for non-conventional transformers. Let's talk about your individual requirements - CONTACT US TODAY!
Show all investments...

SOSV
VC Fund · Princeton, New Jersey, United States · 5 investments in Austria Biotech startups, 75 in the past 12 months

SOSV is a global, deep tech venture capital firm that operates the HAX and IndieBio startup development programs focused on human and planetary health. SOSV invests $500,000 in startups at their inception as they onboard either HAX or IndieBio for a 4-6 month period designed to accelerate the raise of their next institutional round. SOSV joins thelater rounds of HAX and IndieBio graduates. HAX, based in a 35,000 sq ft facility in Newark, NJ, is equipped with machine tools, 3D printers, chemical, electrical and mechanical engineering labs, as well as on-staff engineering and design experts. SOSV's IndieBio has locations in NYC and San Francisco, both of which offer extensive services and facilities to founders including on-site BSL-2 labs, well equipped lab benches and hoods, and advanced lab equipment, such as chromatography equipment.

Show more...

Investment focus

  • Industry: Biotechnology, Health Care, Software
  • Stage:Seed, Convertible Note, Pre-Seed
  • Geography: United States, India, United Kingdom

Investor stats

  • Total investments: 1482
  • Lead/follow: no public data

Portfolio highlights

  • MixRift — MIXRIFT - game developers specialized in Mixed Reality
  • unspun — From 3D scan to perfect fitting custom jeans. unspun makes each pair of jeans unique to your actual body and design. On a mission to reduce global carbon emissions by 1%. As seen in Fast Company's World Changing Ideas, Time's Best Inventions, and PopSci's Best of What's New. Welcome to the future of apparel.
  • Mesa Quantum — Unlock the potential of chip-scale quantum sensing for enhanced Position, Navigation, And Timing capabilities. Explore Mesa Quantum's practical solutions.
Show all investments...

austria Wirtschaftsservice (aws)
VC Fund · Vienna, Wien, Austria · 5 investments in Austria Biotech startups

The Austrian Economic Service mbH (aws) is the promotional bank of the Federal Government.The aws SME fund is the largest Austrian Fund for silent corporate investments, but also providers of equity. Founded in late 2009 by the Austrian Economic Service mbH (aws) - the Development Bank of the Federal - he has a term until 31/12/2025.The fund is currently endowed with EUR 80 million and participates in medium-sized companies and brings with it a fresh capital to develop new products or processes, for sales development to international expansion.

Show more...

Investment focus

  • Industry: Software, SaaS, Information Technology
  • Stage:Seed, Grant, Pre-Seed
  • Geography: Austria, Belgium

Investor stats

  • Total investments: 59
  • Round size: Seed $439k–$2.7M; Grant $62k–$603k; Pre-Seed $44k–$1.9M
  • Lead/follow: 25% lead, 75% follow
  • Last fund: May invest from a new fund soon — last raise in 2013

Portfolio highlights

  • Digicust — Extend your existing customs software by adding AI customs agents to automate customs declarations and save time and money.
  • Repentium — Repentium serves industrial manufacturers seeking reproducible, cost-efficient 3D printing and engineering-grade plastic parts.
  • Another Earth — Another Earth is building an AI-powered simulation and synthetic data platform for Earth Observation. As our planet changes, AI models need scalable, high-quality training data to keep pace. Another Earth provides synthetic data, scenario simulations and predictions required to accelerate AI development, and enable faster, smarterdecision-making—enabling smarter decisions for a more resilient world.
Show all investments...

MIG Capital
VC Fund · München, Bayern, Germany · 4 investments in Austria Biotech startups

MIG Capital is one of the leading German VC Investors. We invest in European Deep Tech and Life Sciences from early to late stage (Seed, Series A, and beyond). We use investments to shape a better tomorrow, today. Our team currently manages 17 MIG public venture capital funds regulated by BaFin, the German financial markets authority. These fundsoperate with more than EUR 1.2 billion capital committed by >60,000 private investors across Germany and Austria.Today, our portfolio consists of 30 companies.

Show more...

Investment focus

  • Industry: Biotechnology, Health Care, Therapeutics
  • Stage:Series A, Series B
  • Geography: Germany, France, Austria

Investor stats

  • Total investments: 96
  • Round size: Series A $2.2M–$40M; Series B $1.6M–$54M
  • Lead/follow: 45% lead, 55% follow
  • Last fund: May invest from a new fund soon — raised $70M in 2014

Portfolio highlights

  • NcodiN — The High Performance Computing (HPC) and ArtificiaI Intelligence (AI) era requires unprecedented computing capabilities. With this in view, industry is heading towards zettascale supercomputers, based on >100k processing units. Chiplets-based disaggregated processors and memory-centric computing architectures are taking over and require an ever more intensive communication between dies. Thus, today interconnect bottleneck is the main
  • GlassPoint Solar — GlassPoint provides solar steam generators to the oil and gas industry for applications such as Enhanced Oil Recovery. It replaces gas-fired steam generation with solar, GlassPoint can reduce EOR gas consumption by up to 80 percent. The company was founded in 2008 and headquartered in Fremont, California.
  • Zadient Technologies — Zadient produces semiconductor manufacturing materials that are critical for the entire silicon carbide (SiC) value chain
Show all investments...

aws Gründungsfonds
VC Fund · Vienna, Wien, Austria · 3 investments in Austria Biotech startups

aws Gründerfonds is Austria's 70m venture capital fund. We invest as co-investor in Austrian high-growth start-ups in their later seed and (pre-)series-A stages.

Show more...

Investment focus

  • Industry: Software, SaaS, Information Technology
  • Stage:Seed, Series A
  • Geography: Austria, Germany, United States

Investor stats

  • Total investments: 85
  • Round size: Seed $1.1M–$5.2M; Series A $1.1M–$12M
  • Lead/follow: 13% lead, 87% follow

Portfolio highlights

  • Upnano — Upnano engages in the manufacture and commercialization of 3D printing systems.
  • OPTIMUSE — Optimuse provides an AI-based solution that supports the pre-design phase of building renovation. The platform converts building data into a digital twin to create accurate models for planning. It integrates data such as room types, thermal properties, and HVAC systems. The system runs energy simulations to calculate heating, cooling, lighting, andequipment needs. It helps design technical systems by defining the quantity, sizing, and configuration of components. The platform develops renovation plans by modeling financial, energy, and emissions outcomes. It also offers tools for cost calculation, performance monitoring, and collaboration across project teams.
  • vitrealab — Enlighten. Your perspective. Light Engines for AR glasses.
Show all investments...

10x Founders
VC Fund · Munich, Bayern, Germany · 2 investments in Austria Biotech startups

Cutting-edge venture capital firm supporting the early-stage entrepreneurs building global businesses.

Show more...

Investment focus

  • Industry: Software, Information Technology, Artificial Intelligence
  • Stage:Seed, Series A, Pre-Seed
  • Geography: Germany, United States, Switzerland

Investor stats

  • Total investments: 87
  • Round size: Seed $2.7M–$12M; Pre-Seed $1.1M–$12M; Series A $6.9M–$60M
  • Lead/follow: 16% lead, 84% follow

Portfolio highlights

  • Raus — Raus is a hospitality-tech startup that offers new opportunities to take a break from big city life. Raus serves as a welcome escape from the seemingly endless demands and constant stimuli of modern life with perfectly simple cabins, close enough for a spontaneous getaway, far enough away to completely unwind.
  • Magic — Teaching AI to act in its natural environment, the computer.
  • Freeform — Freeform simplifies metal printing at any scale for all industries. Parts as a service to help you go from idea to production in days.
Show all investments...

VP Venture Partners
VC Fund · Zürich, Zurich, Switzerland · 2 investments in Austria Biotech startups

VP Venture Partners is a venture capital firm invests in healthcare companies.

Show more...

Investment focus

  • Industry: Medical, Health Diagnostics, Internet
  • Stage:Seed
  • Geography: Austria, Switzerland

Investor stats

  • Total investments: 3
  • Round size: Seed $3M–$3.3M
  • Lead/follow: 67% lead, 33% follow

Portfolio highlights

  • Diamens — Diamens is a company focused on femtech that develops a non-invasive menstrual blood-based molecular diagnostic to detect women-specific diseases like endometriosis.
  • Moonlight AI — Moonlight AI empowers pathologists and hematologists to make therapeutic decisions backed by genomic insight. Moonlight AI was founded in 2022 and is headquartered in Jura, Switzerland.
  • aTension.life — aTension.life is a company focused on advancing the diagnosis and treatment of hypertension through precision medicine. It employs cutting-edge mass spectrometry technology to identify the underlying causes of uncontrolled hypertension using a single blood sample. aTension.life aims to provide personalized diagnostic solutions that enhance patientcare and support laboratories with accurate and reliable tools. The company's mission is to improve the quality of life for hypertensive patients by making advanced diagnostics widely accessible and enabling more effective, individualized therapies.
Show all investments...

bmp Ventures
VC Fund · Berlin, Berlin, Germany · 2 investments in Austria Biotech startups, 8 in the past 12 months

bmp Ventures is an innovative Venture Capital Company from Berlin. Since 1997 we’ve been investing Smart Money in Early Stage and Growth Startups. We finance ingenious business models with outstanding teams, who build fast-growing and sustainably profitable enterprises.

Show more...

Investment focus

  • Industry: Software, Information Technology, Manufacturing
  • Stage:Seed, Series A
  • Geography: Germany, United States, Austria

Investor stats

  • Total investments: 119
  • Round size: Seed $151k–$3.8M; Series A $30k–$5.9M
  • Lead/follow: 39% lead, 61% follow
  • Last fund: Likely actively investing — fund raised in 2024

Portfolio highlights

  • Sedivention — Fight obesity within 20 minutes - fast, effective, long-term. A new weight-loss therapy for the treatment of obesity. Just a view minutes will change your life.
  • Solar Materials — SOLAR MATERIALS developed a recycling technology for solar modules, which recovers all raw materials for a circular solar industry.
  • Litherm Technologies — Litherm Technologies GmbH is a German deep‑tech startup focused on decarbonizing lime and cement production using fully electric kiln technology.
Show all investments...

Access 48,091 investors

822 industries, 177 countries. Updated daily. Emails and phones included.

Browse database — It's Free!
Longevitytech.fund
VC Fund · Prague, Hlavni mesto Praha, Czech Republic · 2 investments in Austria Biotech startups

Investing globally in technologies extending healthy lifespans

Show more...

Investment focus

  • Industry: Biotechnology, Health Care, Life Science
  • Stage:Seed, Convertible Note, Pre-Seed
  • Geography: United States, United Kingdom, The Netherlands

Investor stats

  • Total investments: 49
  • Round size: Seed $1.7M–$10M; Pre-Seed $100k–$3.2M
  • Lead/follow: 31% lead, 69% follow
  • Last fund: Likely still investing — fund raised in 2022

Portfolio highlights

  • Whytics — DAGI: higher-level causal models from spatiotemporal coarse‑graining Whytics builds tools to reveal and validate macro‑causal structure—the stable, higher-level variables that appear when many parts of a system interact across space and time.
  • Klothea Bio — Klothea Bio is a protein well known for its powerful anti-aging capabilities, such as tumor suppression, neuroprotection, and antioxidative actions. As people age, their klotho levels drop to harmful levels. The metabolic disease syndrome will be the focus of the first investigations, while later studies will try to extend therapeutic applicationsto cancer, Alzheimer's disease, obesity, and other age-related diseases.
  • Yuva Biosciences — Using cutting edge mitochondrial science to develop cosmeceuticals and pharmaceuticals.
Show all investments...

Gamma Capital Partners
VC Fund · Vienna, Wien, Austria · 2 investments in Austria Biotech startups

gcp gamma capital partners is an independent Venture Capital investment firm, focused on financing dynamic technology companies in Austria, Germany, Switzerland and CEE countries.They seek to achieve superior returns by finding assets with substantial potential in their regional and sectoral focus areas, before they appear on the radar screenof mainstream players in terms of stage and/or initial investment size.

Show more...

Investment focus

  • Industry: Software, Manufacturing, Information Technology
  • Stage:Series A, Seed
  • Geography: Austria, United States, Germany

Investor stats

  • Total investments: 29
  • Round size: Seed $406k–$636k; Series A $1.3M–$8M
  • Lead/follow: 21% lead, 79% follow

Portfolio highlights

  • Icomasoft — Icomasoft ag is a Swiss pioneer of agent-less software solutions providing unprecedented transparency across your virtual and physical IT infrastructure in heterogeneous datacenters.IcomasoftÂ:registered: software solutions collect essential information for mission-critical and business-critical decisions and provide simplified, automated tasksthat support administrators, IT managers and Executives to easily and confidently analyze, plan and optimize their IT capacity. icomasoftÂ:registered: software solutions are vital for your datacenter clarity.
  • Henn GmbH & Co KG — Henn GmbH & Co KG develops and commercializes rapid connecting systems for hoses in automotive engine blocks.
  • CNSystems Medizintechnik — CNSystems Medizintechnik sells, manufactures, and develops equipment for non-invasive, continuous monitoring of blood pressure and other essential vital parameters. The company was founded in May 1998 as a spin-off from the Medical University and University of Technology Graz, Austria.
Show all investments...

Arax Capital Partners
VC Fund · Vienna, Wien, Austria · 2 investments in Austria Biotech startups

ARAX Capital Partners is an Austrian bio-tech and high-tech early stage investor with an exclusive focus on Austrian ventures. Companies need to be young, innovative (if possible with patentable technology) and must have already secured pre-seed funding to qualify for an investment

Show more...

Investment focus

  • Industry: Biotechnology, Health Care, Medical
  • Stage:Seed
  • Geography: Austria

Investor stats

  • Total investments: 5
  • Lead/follow: 40% lead, 60% follow

Portfolio highlights

  • AFFiRiS — AFFiRiS AG, a Vienna, Austria-based developer of tailor-made peptide vaccines for Alzheimer's disease, Atherosclerosis, Parkinson's disease, hypertension and several other conditions.
  • Greenpass — Greenpass is a ClimateTech company providing the official greenpass for climate proof real estate. Build resilience and manage climate-proof assets and portfolios in line with ESG regulations while maximizing return on invest and value with ease.
  • Calyxha Biotechnologies GmbH — A new perspective on inflammation
Show all investments...

APEX Ventures
VC Fund · Vienna, Wien, Austria · 2 investments in Austria Biotech startups

APEX Ventures is a deep-tech and medical-focused venture capital firm.

Show more...

Investment focus

  • Industry: Artificial Intelligence, Software, Health Care
  • Stage:Seed, Series A, Pre-Seed
  • Geography: Germany, United Kingdom, Austria

Investor stats

  • Total investments: 53
  • Round size: Seed $1.3M–$8M; Pre-Seed $511k–$3M; Series A $2.2M–$21M
  • Lead/follow: 32% lead, 68% follow
  • Last fund: May invest from a new fund soon — last raise in 2020

Portfolio highlights

  • GEMESYS — Gemesys creates a chip that functions similarly to the human brain in order to overcome processing constraints and empower AI with the hardware it needs to complete its destiny
  • HyperHeat — HyperHeat is building a cutting-edge, all-electric heating solution designed to reach temperatures of up to 2,000°C. Using renewable electricity HyperHeat is providing an efficient alternative to fossil fuel combustion. With an efficiency rate of up to 98%, HyperHeat is ideal for retrofitting industrial processes, enabling significant CO2reductions across industries like steel, cement, and chemicals. The scalable technology offers a cost-efficient approach to decarbonizing thermal processes, with a potential to reduce global CO2 emissions by over 4.5 gigatons annually.
  • TriLite Technologies — The world's smallest projection displays from TriLite take laser beam scanning technology to the next level, for augmented vision as light as the eyewear of today.
Show all investments...

R42 Group
VC Fund · Stanford, California, United States · 2 investments in Austria Biotech startups

R42 Group is a venture fund and an institute which invents, invests and informs covering AI, deep science, 5G mobile, biotech and fintech.

Show more...

Investment focus

  • Industry: Biotechnology, Health Care, Software
  • Stage:Seed, Pre-Seed
  • Geography: United Kingdom, United States, Austria

Investor stats

  • Total investments: 30
  • Round size: Seed $654k–$8M; Pre-Seed $439k–$2M
  • Lead/follow: 30% lead, 70% follow

Portfolio highlights

  • Healx — At Healx we use AI drug discovery to develop new treatments for rare diseases. We bring treatments from prediction to patient.
  • Stamp Free — stampfree.ai Digital Shipping Solutions enables customers to send parcels and returns with just a phone conveniently and securely.
  • WiseWorks — AI-Powered Communications Intelligence for Financial Institutions
Show all investments...

Aescap Venture
VC Fund · Amsterdam, Noord-Holland, The Netherlands · 2 investments in Austria Biotech startups

Aescap Venture is an Amsterdam-based investment company that pursues investments in biotech companies in Europe and the U.S.

Show more...

Investment focus

  • Industry: Biotechnology, Pharmaceutical, Chemical
  • Stage:Series A, Series B
  • Geography: United Kingdom, Austria, Belgium

Investor stats

  • Total investments: 18
  • Round size: Series A $1.5M–$20M; Series B $5.2M–$33M
  • Lead/follow: 44% lead, 56% follow

Portfolio highlights

  • Biocartis — Biocartis is an innovative molecular diagnostics company committed to revolutionize molecular testing with its unique proprietary IdyllaTM platform. We provide next generation diagnostic solutions aimed at improving clinical practice for the benefit of patients, clinicians, payers and the healthcare industry, with a focus on oncology.
  • Vivendy Therapeutics — Vivendy Therapeutics Ltd. has developed a specific recombinant human N-acetylgalactosamine-6-sulfatase (rhGALNS) that is specifically modified to improve enzyme activity - enhancing the efficacy of the therapy in MPS IVA significantly
  • Affectis Pharmaceuticals — Affectis is a pharmaceuticals company developing novel drugs for the treatment of neurodegenerative and neuroinflammatory diseases.
Show all investments...

Übermorgen Ventures
VC Fund · Zürich, Zurich, Switzerland · 2 investments in Austria Biotech startups

We are an early stage VC for climate tech startups.

Show more...

Investment focus

  • Industry: Software, Energy, Renewable Energy
  • Stage:Seed, Pre-Seed, Series A
  • Geography: Germany, Switzerland, Finland

Investor stats

  • Total investments: 51
  • Round size: Seed $2.2M–$6.2M; Pre-Seed $344k–$4.2M; Series A $2.7M–$12M
  • Lead/follow: 22% lead, 78% follow

Portfolio highlights

  • UNOWN — Unown is a service and SaaS provider for the fashion industry. Our goal is to revolutionize the way we buy & sell clothing and thereby save 100,000 tons of CO2e every year. We believe that through our leasing, subscription and pre-loved services, we can use resources smarter and create higher value per asset.We enable brands to secure theirshare in the growing secondary markets. They lease out their assets through our revenue share model and get access to deep usage data. We enable customers to experience fashion with a completely new mindset. Our service allows them to rotate their wardrobe while maintaining an efficient and conscious lifestyle.
  • Verna — Verna is a business using geospatial data science to address the climate and nature crises.We help landowners, investors, and policymakers to use land in ways that draw down carbon, enhance biodiversity and generate sustainable returns – e.g. through woodland creation, habitat creation and enhancement, and regenerative agriculture.Verna wasestablished in Borehamwood, Hertford.
  • Ostrom — We make energy fair, smart and green - one flexible monthly plan with no hidden fees, digital-first and 100% renewable energy.
Show all investments...

Lansdowne Partners
VC Fund · London, England, United Kingdom · 2 investments in Austria Biotech startups

Fundamental Equity Investing, since 1998

Show more...

Investment focus

  • Industry: Biotechnology, Finance, Genetics
  • Stage:Series A, Series B
  • Geography: United Kingdom, Austria, United States

Investor stats

  • Total investments: 43
  • Round size: Series A $6.8M–$55M; Series B $8.5M–$100M
  • Lead/follow: 21% lead, 79% follow
  • Last fund: May invest from a new fund soon — last raise in 2017

Portfolio highlights

  • Nattergal — Nattergal is a company with a mission to deliver nature recovery at scale, to provide vital benefits for society and sustainable financial returns.
  • G.ST Antivirals — G.ST Antivirals focuses on the development of antiviral drugs. G.ST Antivirals utilizes the viral dependency on the host cell metabolism and exploits this to design specific interventions counteracting viral nutrient supply.
  • amnis — Check out your possibilities to transfer money abroad, collect international payments and exchange currencies all in one account. Make payments fast with amnis.
Show all investments...

TSVC
VC Fund · Los Altos, California, United States · 2 investments in Austria Biotech startups

Founded in 2010, TSVC (formerly TEEC Angel Fund) is proud to be a leading early-stage venture capital fund in Silicon Valley.

Show more...

Investment focus

  • Industry: Software, Artificial Intelligence, Health Care
  • Stage:Seed, Series A
  • Geography: United States, China, Canada

Investor stats

  • Total investments: 247
  • Round size: Seed $500k–$7M; Series A $2M–$27M
  • Lead/follow: 7% lead, 93% follow
  • Last fund: Likely still investing — fund raised in 2021

Portfolio highlights

  • Angle Health — Digital-First Health Plans For The Modern Employee
  • BloomTech — BloomTech provides online technical coding courses including data science, full-stack web and backend development, and free coding courses.
  • GiftedMom — GiftedMom - using mobile-based solutions to increase maternal engagement.
Show all investments...

BackBone Ventures
VC Fund · Zurich, Zurich, Switzerland · 2 investments in Austria Biotech startups

BackBone Ventures' focus are early-stage investments, primarly in the area of innovative ICT, FoodTech and disruptive technologies in DACH & Israel. Committed to achieve a positive impact for the next generation by empowering access to proficient ventures investments.

Show more...

Investment focus

  • Industry: Artificial Intelligence, Information Technology, Software
  • Stage:Pre-Seed, Seed, Series A
  • Geography: Switzerland, Germany, Israel

Investor stats

  • Total investments: 69
  • Round size: Seed $966k–$5M; Pre-Seed $583k–$2.1M; Series A $5M–$105M
  • Lead/follow: 25% lead, 75% follow

Portfolio highlights

  • Evoralis — Evoralis is an enzyme development company that specializes in the discovery and development of plastic-depolymerizing enzymes. It is a spin-out from the University of Cambridge.
  • Proofcheck — Proofcheck is a multilingual AI proofreading platform and a collaborative in-browser workspace for PDFs and epubs. Their next-generation AI workflow and collaboration tool helps content creators quickly catch costly mistakes before they reach audiences. Proofcheck is headquartered in Vienna, Wien and was founded in 2022.
  • Voliro — The multi-purpose robotic flight platform redefining work at height. NDT Solutions for elevated insights about your critical infrastructure.
Show all investments...

Access 48,091 investors

822 industries, 177 countries. Updated daily. Emails and phones included.

Browse database — It's Free!
Nina Capital
VC Fund · Barcelona, Catalonia, Spain · 2 investments in Austria Biotech startups, 10 in the past 12 months

We deploy early stage capital to fuel the growth of need-driven health technology companies.

Show more...

Investment focus

  • Industry: Health Care, Artificial Intelligence, Software
  • Stage:Seed, Pre-Seed, Series A
  • Geography: United States, United Kingdom, Germany

Investor stats

  • Total investments: 85
  • Round size: Seed $2M–$5.2M; Pre-Seed $573k–$2.4M; Series A $5M–$22M
  • Lead/follow: 41% lead, 59% follow
  • Last fund: Likely actively investing — fund raised in 2025

Portfolio highlights

  • Navidence — Navidence provides a transformative Real World Evidence (RWE) Design platform that enables organizations to efficiently adapt to the ever-increasing ecosystem of Real World Data (RWD) sources. The company unlocks the power of Computable Operational Definitions (CODefs) for RWE Design and RWD Assessment. Navidence's RWE Sherpa platform offerstools to streamline the process of defining an RWE study's data, making it easier for researchers to conduct their studies in the age of data.
  • Rivia — Integrated Clinical Trial Intelligence. Drive therapeutic evaluation and trial management with real-time insights.
  • Sober Sidekick — Gamified peer to peer support
Show all investments...

eQventure
VC Fund · Graz, Steiermark, Austria · 2 investments in Austria Biotech startups

Entrepreneurs for Entrepreneurs

Show more...

Investment focus

  • Industry: Software, Information Technology, Artificial Intelligence
  • Stage:Seed, Series A
  • Geography: Austria, Switzerland

Investor stats

  • Total investments: 57
  • Round size: Seed $549k–$1.2M; Series A $768k–$6.6M
  • Lead/follow: 79% lead, 21% follow

Portfolio highlights

  • Diamens — Diamens is a company focused on femtech that develops a non-invasive menstrual blood-based molecular diagnostic to detect women-specific diseases like endometriosis.
  • Respory — Respory provides real-time people-tracking using proprietary radar sensors, all without capturing personal data. Our scalable sensor network, powered by AI-driven algorithms, delivers precise customer journey insights, critical for in-store performance in retail.
  • 2nd Cycle — 2nd Cycle creating a cost-effective, fully automated, and scalable solution for modules for a second life cycle.
Show all investments...

red-stars.com
VC Fund · 2 investments in Austria Biotech startups

We back B2B software and life-sciences companies with limitless scalability.

Show more...

Investment focus

  • Industry: Software, Biotechnology, Telecommunications
  • Stage:Seed, Series A
  • Geography: Austria, Germany

Investor stats

  • Total investments: 8
  • Round size: Seed $1.6M–$4.4M
  • Lead/follow: 75% lead, 25% follow

Portfolio highlights

  • Txture — End-To-End Cloud Transformation Platform
  • HeartBeat.bio — HeartBeat.bio is a privately funded drug discovery company focusing on the development of a high-throughput 3D screening platform for heart failure and cardiomyopathies.
  • MAVOCO — We create a carrier-grade software for IoT champions, trusted by tier-1 Mobile network operators.
Show all investments...

The Austrian Research Promotion Agency (FFG)
VC Fund · Vienna, Wien, Austria · 2 investments in Austria Biotech startups

The Austrian Research Promotion Agency (FFG) is the national funding agency for industrial research and development in Austria. As a "one-stop shop" offering a diversified and targeted programme portfolio, the FFG gives Austrian businesses and research facilities quick and uncomplicated access to research funding.The FFG was foundedon 1 September 2004 (pursuant to the FFG Act on establishing a research promotion agency, Federal Law Gazette I No. 73/2004). The FFG is wholly owned by the Republic of Austria, represented by the Federal Ministry for Transport, Innovation and Technology (bmvit) and the Federal Ministry of Science, Research and Economy (BMWFW). As a provider of funding services, however, the FFG also works for other national and international institutions.

Show more...

Investment focus

  • Industry: Software, Artificial Intelligence, Medical
  • Stage:Grant, Seed, Pre-Seed
  • Geography: Austria, United States, Belgium

Investor stats

  • Total investments: 70
  • Round size: Seed $300k–$2.2M; Grant $67k–$3.5M; Pre-Seed $480k–$1.9M
  • Lead/follow: 27% lead, 73% follow

Portfolio highlights

  • OPTIMUSE — Optimuse provides an AI-based solution that supports the pre-design phase of building renovation. The platform converts building data into a digital twin to create accurate models for planning. It integrates data such as room types, thermal properties, and HVAC systems. The system runs energy simulations to calculate heating, cooling, lighting, andequipment needs. It helps design technical systems by defining the quantity, sizing, and configuration of components. The platform develops renovation plans by modeling financial, energy, and emissions outcomes. It also offers tools for cost calculation, performance monitoring, and collaboration across project teams.
  • sequestra — Sequestra is developing a technology platform that allows for permanent binding of CO₂ in industrial residues such as steel slag, incineration ash, and demolition waste while making the carbonated materials usable for construction applications.
  • Another Earth — Another Earth is building an AI-powered simulation and synthetic data platform for Earth Observation. As our planet changes, AI models need scalable, high-quality training data to keep pace. Another Earth provides synthetic data, scenario simulations and predictions required to accelerate AI development, and enable faster, smarterdecision-making—enabling smarter decisions for a more resilient world.
Show all investments...

PUSH VC
VC Fund · Vienna, Wien, Austria · 2 investments in Austria Biotech startups

| Investments that move industries

Show more...

Investment focus

  • Industry: Software, Apps, Health Care
  • Stage:Seed, Series A
  • Geography: Austria, Germany, United States

Investor stats

  • Total investments: 39
  • Round size: Seed $650k–$8.1M; Series A $5M–$32M
  • Lead/follow: 18% lead, 82% follow
  • Last fund: Likely still investing — fund raised in 2022

Portfolio highlights

  • Gustav — Modern staffing teams use Gustav's VMS to source talent from trusted sub-vendors. Fast, secure, and compliant!
  • raicoon — SaaS solution for autonomous operations of renewable energy
  • Valutico — Valutico is the world‘s leading provider of web-based company valuation tools.Started in 2014 by a team of enthusiastic Corporate Finance professionals and web developers, the concept was born out of frustration with the status-quo in Corporate Finance practice: That professional company valuations used to be the domain of only the mostsophisticated of investors.At Valutico, it has been their mission from the outset to offer cutting-edge valuation tools to a much wider audience. Today they empower everybody to perform company valuations that meet and exceed the standards of even the leading investment banks and advisory firms.The company today is headquartered in Vienna/Austria and has an additional office in Frankfurt/Germany.
Show all investments...

FPS-Holding
VC Fund · 2 investments in Austria Biotech startups

Investment focus

  • Industry: Biotechnology, Health Diagnostics
  • Stage:Seed
  • Geography: Austria

Investor stats

  • Total investments: 2
  • Round size: Seed $420k–$429k
  • Lead/follow: 50% lead, 50% follow

Portfolio highlights

  • Sola Diagnostics — Product: Sola Diagnostics’ WID®-easy test is a non-invasive epigenetic solution for detecting endometrial cancer in women with abnormal uterine bleeding. By analyzing DNA methylation markers from a simple vaginal swab, it offers high accuracy, reducing false positives and unnecessary surgeries. Target Audience: Designed for gynecologists andhealthcare providers, WID®-easy streamlines diagnostics, cutting costs and false alarms. Women benefit from a painless, accessible test that ensures earlier and more precise detection. Technology: Powered by advanced DNA methylation research, WID®-easy identifies cancer-specific epigenetic markers. With PCR-based analysis and robust clinical validation, it delivers fast, reliable results that integrate seamlessly into medical workflows. Market Positioning: WID®-easy fills a critical gap as a first-line diagnostic for abnormal uterine bleeding. Its clinical validation, accuracy, and cost-efficiency set it apart from invasive procedures. Its ease of use and scalability position it for widespread adoption. Milestones: Sola Diagnostics launched in Austria and Switzerland in 2024 and expanded to Great Britain in 2025. UKCA Marking was registered in December 2024. So far, private equity investments totaling €2.4M have supported Sola's mission to revolutionize women’s health diagnostics.
Show all investments...

HackCapital
VC Fund · Lausanne, Vaud, Switzerland · 1 investments in Austria Biotech startups

Join FoodTech focused investors looking to back impact-driven founders shaping our food system

Show more...

Investment focus

  • Industry: Biotechnology, Food and Beverage, Food Processing
  • Stage:Seed, Pre-Seed, Series A
  • Geography: United States, Israel, United Kingdom

Investor stats

  • Total investments: 28
  • Lead/follow: no public data

Portfolio highlights

  • twig bio — twig bio operates as a bioengineering startup. twig bio using AI and robotics to find sustainable replacements for harmful ingredients.
  • Cultivated Biosciences — Cultivated - Creamy, dairy-free indulgence
  • UNCAGED Innovations — What if we could make leather without the animal? We are a biomaterials company combining the power of nature and technology to reimagine leather.
Show all investments...

IBG Beteiligungsgesellschaft Sachsen-Anhalt
VC Fund · Magdeburg-rothensee, Sachsen-Anhalt, Germany · 1 investments in Austria Biotech startups

IBG Beteiligungsgesellschaft Sachsen-Anhalt is a venture capital firm makes investments in territories such as Germany and Denmark.

Show more...

Investment focus

  • Industry: Electronics, Software, Medical Device
  • Stage:Seed, Series A
  • Geography: Germany, Austria

Investor stats

  • Total investments: 12
  • Lead/follow: no public data

Portfolio highlights

  • Livil — Livil provides a toolkit for designing and delivering flexible employee benefits, including lifestyle, dental, and vision plans.
  • Wingfield — Wingfield develops a system intended to transform any tennis court in the world into a smart court. The system is a combination of hardware and artificial intelligence and keeps track of the score, analyzes strokes and gives personal feedback right after matches or practice sessions and the system only costs a fraction of a professional system andis easily set up, enabling players to get the same game analytics as the professionals do.
  • Baby Sweets — Baby Sweets provides Online shop for beautiful and unusual baby clothes and accessories.Sales of own brands made in EU as well as international brands.
Show all investments...

Santo Holding
VC Fund · Zürich, Zurich, Switzerland · 1 investments in Austria Biotech startups

Santo Holding is a Zurich-based investment firm funding biotechnology, pharmaceutical, life sciences, and healthcare companies.

Show more...

Investment focus

  • Industry: Biotechnology, Energy, Medical
  • Stage:Series B, Series C
  • Geography: Germany, Austria

Investor stats

  • Total investments: 6
  • Lead/follow: 50% lead, 50% follow

Portfolio highlights

  • AFFiRiS — AFFiRiS AG, a Vienna, Austria-based developer of tailor-made peptide vaccines for Alzheimer's disease, Atherosclerosis, Parkinson's disease, hypertension and several other conditions.
  • SuppreMol — SuppreMol is a privately held biotechnology company that pioneers a novel approach for the treatment of autoimmune diseases which could lead to the cure of these disorders instead of merely treating their symptoms.
  • Efficient Energy — Efficient Energy GmbH is an innovative manufacturer and system supplier of environmentally friendly refrigeration technology, based in Feldkirchen near Munich, Germany. The company developed the Bluezero-technology, which uses water as a refrigerant and and thereby entirely avoids fluorinated refrigerants (HFCs). Efficient Energy helps itscustomers overcome the increasing regulatory challenges of refrigeration technology, and offers them long-term, sustainable solutions with its eChiller model range. The eChiller chilled water units are ideally suited for process cooling, machine cooling and the cooling of technical equipment and data centres and provide cooling capacities from 35 kW to 120 kW, depending on the model. With its outstanding cost efficiency and low CO2 footprint, companies benefit on many fronts. The pioneering technology has also been noticed by politics and the media, and has received multiple awards for the eChiller. These include among others the European Business Award for the Environment 2018/2019 from the European Comission and the Red Herring Europe Top 100 in 2020.
Show all investments...

Clima Now
VC Fund · Zürich, Zurich, Switzerland · 1 investments in Austria Biotech startups

Wir wollen unser wichtigstes Erbe erhalten. Eine lebenswerte Erde.

Show more...

Investment focus

  • Industry: Farming, Renewable Energy, Solar
  • Stage:Seed, Grant, Pre-Seed
  • Geography: Switzerland, Germany, Austria

Investor stats

  • Total investments: 8
  • Lead/follow: no public data

Portfolio highlights

  • Planeteers — We capture CO2 in water and unleash the potential of the oceans as the largest carbon sink on our planet.
  • Infrascreen — The transparent aluminium screen for extra energy-savings in greenhouses. Thanks to it's low-e coating, it saves up to 20% more than a regular energy-saving screen
  • Kynda — Keen 4 Greens offers a wide range of vegan products. Founded in 2019, Keen 4 Greens is based in Hamburg, Germany.
Show all investments...

Access 48,091 investors

822 industries, 177 countries. Updated daily. Emails and phones included.

Browse database — It's Free!
Lansdowne Investment Company Cyprus
VC Fund · 1 investments in Austria Biotech startups

Lansdowne Investment Company Cyprus

Show more...

Investment focus

  • Industry: Life Science, Biotechnology, Semiconductor
  • Stage:Seed
  • Geography: Austria

Investor stats

  • Total investments: 1
  • Lead/follow: no public data

Portfolio highlights

  • Sarcura — Sarcura GmbH is an Austrian deep-tech startup developing an instrument platform for the industrial manufacturing of advanced cell therapies. Our platform combines silicon chip technology and microfluidic processing to enable real-time process control and manipulation on a cellular level, enabling a fully automated and modular manufacturing system..
Show all investments...

Axilium Holding
VC Fund · 1 investments in Austria Biotech startups

Axilium Holding

Show more...

Investment focus

  • Industry: Life Science, Biotechnology, Semiconductor
  • Stage:Seed
  • Geography: Austria

Investor stats

  • Total investments: 1
  • Lead/follow: no public data

Portfolio highlights

  • Sarcura — Sarcura GmbH is an Austrian deep-tech startup developing an instrument platform for the industrial manufacturing of advanced cell therapies. Our platform combines silicon chip technology and microfluidic processing to enable real-time process control and manipulation on a cellular level, enabling a fully automated and modular manufacturing system..
Show all investments...

Valnon Holding
VC Fund · 1 investments in Austria Biotech startups

Valnon Holding is an investment firm that invest in early-stage companies.

Show more...

Investment focus

  • Industry: Biotechnology, Chemical Engineering
  • Stage:Seed
  • Geography: Austria

Investor stats

  • Total investments: 1
  • Lead/follow: no public data

Portfolio highlights

  • Lignovations — Lignovations develops high-performance ingredients from biomass. Accelerating the transition to a sustainable society.
Show all investments...

RKP InnoInvest
VC Fund · Hartberg, Steiermark, Austria · 1 investments in Austria Biotech startups

RKP InnoInvest provides Investment capital and strategic services support progressive and dynamic start-ups and companies.

Show more...

Investment focus

  • Industry: Biotechnology, Food and Beverage
  • Stage:Seed
  • Geography: Austria

Investor stats

  • Total investments: 2
  • Lead/follow: no public data

Portfolio highlights

  • Hakuma — Hakuma is the full load of Matcha to which mango, lemon, ginger, agave and Baobab join.
  • Econutri — Recycling CO2 for sustainable protein production
Show all investments...

EMBL Ventures
VC Fund · Heidelberg, Baden-Wurttemberg, Germany · 1 investments in Austria Biotech startups

EMBL Ventures invest throughout Europe with the aim to build companies that create significant commercial opportunities based on new therapeutic treatment.

Show more...

Investment focus

  • Industry: Biotechnology, Health Care, Therapeutics
  • Stage:Series A, Series B, Series C
  • Geography: Germany, Austria, Ireland

Investor stats

  • Total investments: 11
  • Round size: Series A $3.9M–$15M; Series B $20M–$70M
  • Lead/follow: 27% lead, 73% follow

Portfolio highlights

  • Arsanis — Arsanis is a clinical-stage biopharmaceutical company focused on applying monoclonal antibody (mAb) immunotherapies to address serious infectious diseases. A deep understanding of the pathogenesis of infection, paired with access to some of the most advanced mAb discovery techniques and platforms available today, has positioned Arsanis to build andadvance a pipeline of novel mAbs with multiple mechanisms of action and high potency against their intended targets.The company’s lead clinical program, ASN100, is aimed at serious Staphylococcus aureus infections and is being evaluated in Phase 2 clinical trial for the prevention of S. aureus pneumonia in high-risk, mechanically ventilated patients. In addition to ASN100, its preclinical pipeline is comprised of mAbs targeting multiple serious bacterial and viral pathogens, including respiratory syncytial virus.Arsanis is a U.S. company headquartered in Waltham, Massachusetts, with European research and preclinical development operations headquartered in Vienna, Austria (Arsanis Biosciences GmbH).
  • Topas Therapeutics — Topas Therapeutics GmbH is a private Hamburg, Germany-based biotechnology company focused on developing products to address areas of major unmet need, including autoimmune diseases, allergies and anti-drug antibodies. The Topas Particle Conjugates technology platform induces antigen-specific immune tolerance by harnessing the liver’s naturalimmunology capabilities. The Company has several proprietary programs; lead product candidate TPM203 has recently entered clinical testing for pemphigus vulgaris, an orphan disease. Other programs are in anti-drug antibodies, celiac disease, Type 1 diabetes, as well as a multiple sclerosis program that is available for partnering.Topas has a research and option agreement with Eli Lilly and Company focused on antigen-specific tolerance induction and a multi-year agreement with Boehringer Ingelheim to collaborate in the field of anti-drug antibodies.Topas’ investors include: Epidarex Capital, Gimv, EMBL Ventures, Evotec and Boehringer Ingelheim Venture Fund.
  • Crescendo Biologics — Crescendo Biologics is a new Cambridge-based company whose vision is to deliver next-generation antibody therapeutics based on novel class-leading platforms.The focus of the company is on developing platforms that will address key issues in generating high-affinity, soluble, human VH antibody fragments. These are the smallest fragments thatretain antibody binding, and have many desirable properties as potential therapeutics. Crescendo will then utilise these platforms for product development of in-house targets or in partnership with other companies.
Show all investments...

EIT Health
VC Fund · Munich, Bayern, Germany · 1 investments in Austria Biotech startups

EIT Health is a network of best-in-class health innovators backed by the EU. We deliver solutions to enable European citizens to live longer, healthier lives.

Show more...

Investment focus

  • Industry: Health Care, Medical Device, Medical
  • Stage:Grant, Pre-Seed, Seed
  • Geography: United Kingdom, Spain, Ireland

Investor stats

  • Total investments: 95
  • Round size: Seed $220k–$1.4M; Grant $22k–$1.6M; Pre-Seed $44k–$1.4M
  • Lead/follow: 60% lead, 40% follow

Portfolio highlights

  • IDOVEN — IDoven develops products to detect heart problems at an early stage to prevent heart diseases.
  • eBreathie — eBreathie is a pioneering digital health startup offering an integrated asthma management solution. Our system comprises a smart inhaler (a medical device) that not only tracks WHEN patients take their medication but also HOW they do it, creating a detailed inhalation profile for each use. Paired with a user-friendly mobile app for patients and acomprehensive patient management platform for doctors, we provide real-time feedback on inhalation efficacy, ensuring patients and healthcare professionals have the insights needed for optimal asthma management. Leveraging IoT and AI, our goal is to reduce emergency visits, asthma attacks, and hospitalizations while ensuring effective inhalation techniques and optimal patient care.
  • Trak — Trak is a software tool for healthcare professional to provide AI-based tele-rehabilitation services like physiotherapy and others.
Show all investments...

HBM Partners
VC Fund · Zug, Zug, Switzerland · 1 investments in Austria Biotech startups

HBM Partners focuses on venture, growth and buy-out financings of private companies as well as investments in public companies.The HBM funds invest in entrepreneurial biopharma and other healthcare-related companies in Europe, North America, India and other Emerging Markets. Their team supports the growth of the portfolio companies through allstages of development, focusing on adding value by leveraging its experience and HBM's world-wide network in the industry. Investments usually range between $5 million to $50 million.

Show more...

Investment focus

  • Industry: Biotechnology, Medical, Health Care
  • Stage:Series B, Series C
  • Geography: United States, Germany, Switzerland

Investor stats

  • Total investments: 41
  • Round size: Series B $7.7M–$125M; Series C $2.5M–$113M
  • Lead/follow: 17% lead, 83% follow
  • Last fund: May invest from a new fund soon — raised $105M in 2012

Portfolio highlights

  • Dren Bio — Dren Bio is a biotechnology company with a portfolio of attractive projects focused on powerful protein engineering technologies for the depletion of cells, protein aggregates, and other disease-causing agents. It is a holding company business model aimed at creating value with multiple projects as stand-alone assets.
  • AtaiBeckley — We are a clinical-stage biopharmaceutical company developing new mental health treatments to transform patient outcomes.
  • Mineralys Therapeutics — Evolving science is revealing the importance of aldosterone in cardio-renal-metabolic diseases.We are focused on improving outcomes for people managing hypertension, CKD and related diseases that are driven by dysregulated aldosterone. About Aldosterone
Show all investments...

FastVentures
VC Fund · Budapest, Budapest, Hungary · 1 investments in Austria Biotech startups

venture capital

Show more...

Investment focus

  • Industry: Software, Biotechnology, Information Technology
  • Stage:Seed, Series A, Series B
  • Geography: Hungary, South Korea, United States

Investor stats

  • Total investments: 26
  • Round size: Seed $424k–$31M; Series A $1.3M–$2.3M
  • Lead/follow: 27% lead, 73% follow

Portfolio highlights

  • Iskra — Iskra offers web3 gaming opportunities using blockchain and rewards its stakeholders based on their participation.
  • On Vacation — On Vacation is a chat-based concierge service where customers may get help making reservations and getting personalized and optimal tours from travel specialists.
  • NextChapter — NextChapter is a digital commerce platform that acquires and operates Coupang and Naver-based online native brands in Korea. NextChapter is backed by BlueRun Ventures/BRV Capital Management, Goodwater Capital, Klim Ventures, Fast Ventures and Sandbox Network.NextChapter was founded in 2021 by Joshua Kwon and Jay Chung and is headquarteredin Seoul, Korea.
Show all investments...

Wellcome Trust
VC Fund · London, England, United Kingdom · 1 investments in Austria Biotech startups, 8 in the past 12 months

Wellcome Trust is a medical research charity that funds research that aims to protect and improving human and animal health. It focuses on the fields of public engagement, investments, innovation, humanities, and social science. It was founded in 1936 and headquartered in London, England.

Show more...

Investment focus

  • Industry: Biotechnology, Health Care, Medical
  • Stage:Grant, Series C
  • Geography: United States, United Kingdom, France

Investor stats

  • Total investments: 121
  • Round size: Grant $1.3M–$8.9M; Series C $10M–$127M
  • Lead/follow: 39% lead, 61% follow
  • Last fund: May invest from a new fund soon — raised $319M in 2018

Portfolio highlights

  • System — System is a free, open, and living public resource that aims to explain how anything in the world is connected to everything else.
  • Lario Therapeutics — Lario Therapeutics is a biopharmaceutical firm that develops precision therapeutics for epilepsy and neurological disorders.
  • Ineffable Intelligence — Ineffable Intelligence develops machine learning systems that learn through interaction and experience. The company works on reinforcement learning approaches that allow models to improve by trial and error rather than relying on large human-generated datasets. Its core work centers on building a “superlearner,” a system designed to generateknowledge and skills by engaging with simulated or real environments.The organization develops algorithms and computational frameworks that support autonomous learning, experimentation, and decision-making processes. Its efforts involve designing AI models that can adapt, refine behavior, and solve complex problems through continuous feedback loops. The company’s research aims to expand how AI systems acquire knowledge and apply it across different domains.
Show all investments...

Possible Ventures
VC Fund · Munich, Bayern, Germany · 1 investments in Austria Biotech startups

Possible Ventures backs ambitious teams building frontier technology to positively impact society. We invest globally in the early stages, actively supporting founders via our collective of global entrepreneurs.

Show more...

Investment focus

  • Industry: Software, Biotechnology, Information Technology
  • Stage:Seed, Pre-Seed, Series A
  • Geography: Germany, Australia, United States

Investor stats

  • Total investments: 163
  • Round size: Seed $1.6M–$10M; Pre-Seed $549k–$3.8M; Series A $9.5M–$44M
  • Lead/follow: 4% lead, 96% follow

Portfolio highlights

  • Eden Brew — Eden Brew is a ground-breaking new way to enjoy dairy products sustainably and nutritiously.
  • Auriga Space — Next-generation space launch company providing frequent, sustainable and affordable transport to low Earth orbit
  • InSpacePropulsion Technologies — Cost-effective, robust, and quickly available propulsion solutions, based on 10+ years of R&D and 40 years of combined experience in space propulsion.
Show all investments...

Access 48,091 investors

822 industries, 177 countries. Updated daily. Emails and phones included.

Browse database — It's Free!
Synthesis Capital
VC Fund · London, England, United Kingdom · 1 investments in Austria Biotech startups

Synthesis Capital is an investment manager transforming our food system through food technology.

Show more...

Investment focus

  • Industry: Biotechnology, Food and Beverage, Organic Food
  • Stage:Seed, Series A, Series C
  • Geography: United States, Israel, Austria

Investor stats

  • Total investments: 10
  • Round size: Seed $7.1M–$9M; Series A $20M–$23M
  • Lead/follow: 60% lead, 40% follow

Portfolio highlights

  • Triplebar — Triplebar provides sustainability, biotechnology, and synthetic biology research.
  • Savor — Savor makes delightfully rich foods without animals, farmland, fertilizers, hormones, or antibiotics.
  • Culture Biosciences — Culture Biosciences develops automated bio-reactor that helps biotech companies optimize their manufacturing processes and brings products to market faster. The company also builds automated tools for fermentation. It has a digital bio-manufacturing platform to enable scientists to run, monitor, and analyze bio-reactors faster than traditionalapproaches by robotic sample handling and cloud data monitoring and analysis.Culture Biosciences was founded in 2016 and is headquartered in San Francisco, California.
Show all investments...

GLS Ventures
VC Fund · Sugar Land, Texas, United States · 1 investments in Austria Biotech startups

GLS Ventures

Show more...

Investment focus

  • Industry: Medical, Health Care, Biotechnology
  • Stage:Series B
  • Geography: Austria

Investor stats

  • Total investments: 2
  • Lead/follow: 0% lead, 100% follow

Portfolio highlights

  • Nabriva Therapeutics — MPOMM Adalah link resmi berlisensi agen mpo slot paling gacor hari ini dengan pilihan bermain di server slot anti rungkat terjamin kemenangan jackpot maxwin menang berapapun akan di bayar lunas
Show all investments...

FCPG Affi
VC Fund · 1 investments in Austria Biotech startups

FCPG Affi

Show more...

Investment focus

  • Industry: Medical, Biotechnology, Pharmaceutical
  • Geography: Austria

Investor stats

  • Total investments: 1
  • Lead/follow: 0% lead, 100% follow

Portfolio highlights

  • AFFiRiS — AFFiRiS AG, a Vienna, Austria-based developer of tailor-made peptide vaccines for Alzheimer's disease, Atherosclerosis, Parkinson's disease, hypertension and several other conditions.
Show all investments...

OrbiMed
VC Fund · New York, New York, United States · 1 investments in Austria Biotech startups

Leading Global Healthcare Platform with Deep Proprietary Resources and Global Industry Coverage.

Show more...

Investment focus

  • Industry: Biotechnology, Health Care, Medical
  • Stage:Series B, Series A, Series C
  • Geography: United States, China, Israel

Investor stats

  • Total investments: 589
  • Round size: Series A $10M–$116M; Series B $24M–$150M; Series C $15M–$143M
  • Lead/follow: 35% lead, 65% follow
  • Last fund: Likely actively investing — fund raised in 2025

Portfolio highlights

  • Sonendo — Sonendo developing innovative technologies to transform dentistry by Saving Teeth Through Sound Science®. The GentleWave® System shows significant improvements in clinical efficacy and practice efficiency when compared to standard root canal treatment.1,2, 3 Sonendo is the parent company of TDO® Software, the developer of the most widely usedendodontic practice management software in the world, designed to simplify practice workflow. TDO software seamlessly integrates practice management, imaging, social media, referral reporting, CBCT imaging, and offers built-in communication with the GentleWave System.
  • Crown Bioscience — Crown Bioscience is an expert preclinical contract research organization providing oncology services and preclinical cancer models for drug development. Crown Biocience brings clarity to drug discovery worldwide, helping companies solve today's most pressing problems in immuno-oncology, oncology, cardiovascular, and metabolic diseases.
  • Aspen Neuroscience — personalized cell therapy Starts with you Learn More about our technology
Show all investments...

Andera Partners
VC Fund · Paris, Ile-de-France, France · 1 investments in Austria Biotech startups

Andera Partners, formerly known as Edmond de Rothschild Investment Partners (EdRIP) As heir to the traditions and values that have ensured the success of the Rothschild family for 250 years, the Edmond de Rothschild Group has established itself over time as a leading player in European finance. Its activities are grouped around two major areas:Private Banking and Asset Management. The Group offers wealthy families, entrepreneurs, and large institutions a full range of solutions combining a culture of tailored solutions, stability, performance, and innovation. The Edmond de Rothschild Group’s offering is characterised by strong convictions, with the desire to guarantee to each of its customers: A unique, close relationship, underpinned by the know-how and the variety of expertise of a large international group; Autonomous, experienced teams, who anticipate economic trends and innovate to establish long-term performance; The recognised stability, strength, and independence of a family-owned financial group. Founded by Baron Edmond de Rothschild in 1953, the Group has been chaired by his son, Baron Benjamin de Rothschild, since 1997.

Show more...

Investment focus

  • Industry: Biotechnology, Health Care, Medical
  • Stage:Series B, Private Equity
  • Geography: France, United States, Germany

Investor stats

  • Total investments: 179
  • Round size: Series B $14M–$85M; Private Equity $110M–$247M
  • Lead/follow: 40% lead, 60% follow
  • Last fund: Likely still investing — raised $466M in 2022

Portfolio highlights

  • Amolyt Pharma — AstraZeneca is a global, science-led biopharmaceutical business and our innovative medicines are used by millions of patients worldwide.
  • ImCheck Therapeutics — ImCheck Therapeutics is a developer of immuno-modulatory antibodies designed for the treatment of cancer and other immune-related diseases. The company's services are engaged in the discovery and development of immunomodulators for treating breast cancer, gastric, ovarian cancer cells and other solid solid tumours.
  • Greywolf Therapeutics — Novel antigen modulation technology that controls T cells to guide the immune system
Show all investments...

Boehringer Ingelheim Venture Fund
VC Fund · Ingelheim Am Rhein, Rheinland-Pfalz, Germany · 1 investments in Austria Biotech startups

Discover Boehringer Ingelheim Venture Fund. We invest in groundbreaking science to transform care. Explore our mission and join us in advancing medicine

Show more...

Investment focus

  • Industry: Biotechnology, Health Care, Therapeutics
  • Stage:Series A, Series B, Seed
  • Geography: United States, Germany, Switzerland

Investor stats

  • Total investments: 98
  • Round size: Seed $1.3M–$20M; Series A $3.8M–$34M; Series B $11M–$50M
  • Lead/follow: 47% lead, 53% follow
  • Last fund: May invest from a new fund soon — raised $250M in 2018

Portfolio highlights

  • ArrePath — ArrePath is an anti-infective drug discovery company addressing the global health challenge of drug resistant infections.
  • Rinri Therapeutics — Rinri Therapeutics has been founded on pioneering research into auditory stem cells led by Professor Marcelo Rivolta at the University of Sheffield.
  • Centauri Therapeutics — At Centauri we seek to tackle life-threatening infectious diseases in the most vulnerable patients.
Show all investments...

Amino Collective
VC Fund · Berlin, Berlin, Germany · 1 investments in Austria Biotech startups

Amino Collective is an institutional venture capital firm investing at seed stage in health and bio companies. They help bring life-changing ideas to life by backing, connecting, and advancing our collective of entrepreneurs and scientists. The firm intends to invest in the sectors of biology, biotech, health tech, science, digital health, lifescience, and synthetic biology.

Show more...

Investment focus

  • Industry: Health Care, Biotechnology, Medical
  • Stage:Seed, Series A, Pre-Seed
  • Geography: United States, United Kingdom, Germany

Investor stats

  • Total investments: 44
  • Round size: Seed $2.4M–$15M; Pre-Seed $125k–$7.8M; Series A $12M–$37M
  • Lead/follow: 5% lead, 95% follow

Portfolio highlights

  • Anima — Anima's online patient triage speeds up the clinical workflow 10x and allows providers to deliver the right care for patients within 24 hours.Millions of patients with serious problems are missed and die every year because there isn’t adequate information flow between medical appointments. Patients submit their problems and requests onAnimainstead of waiting for an appointment, and Anima sends an actionable report to their provider with trends, risks and recommendations.
  • Aware — Aware is a mobile app for evaluating health data and for researching chronic diseases.
  • Nostos Genomics — Our genetic variant interpretation platform enables genetic testing labs to give more people with genetic diseases a clear and fast diagnosis.
Show all investments...

i&i Biotech Fund
VC Fund · Luxembourg, Luxembourg, Luxembourg · 1 investments in Austria Biotech startups

We are i&i Biotech Fund, partners of outstanding founders on their path to global success. We invest in innovative early stage Life Sciences startups.

Show more...

Investment focus

  • Industry: Biotechnology, Health Care, Medical
  • Stage:Seed, Series A
  • Geography: Czech Republic, India, Spain

Investor stats

  • Total investments: 10
  • Lead/follow: no public data

Portfolio highlights

  • Antiverse — Designing biologics for 100 challenging targets
  • Captain T Cell — Captain T Cell is a start-up project that develops T cell-based immunotherapies for cancer patients. The company identifies novel high-efficiency TCRs for the development of T cell immunotherapies. It focuses on CMC- and preclinical development for their lead candidates.
  • Casinvent Pharma — Casinvent Pharma develops new therapeutic options for the treatment of selected malignancies.
Show all investments...

4SC
VC Fund · Planegg, Bayern, Germany · 1 investments in Austria Biotech startups

4SC discovers and develops targeted, small-molecule drugs for the treatment of cancer and autoimmune diseases in indications with high unmet medical needs. These drugs are intended to provide innovative treatment options that are more tolerable and efficacious, and provide a better quality of life.

Show more...

Investment focus

  • Industry: Health Care, Biotechnology
  • Stage:Seed
  • Geography: Austria

Investor stats

  • Total investments: 1
  • Lead/follow: 0% lead, 100% follow

Portfolio highlights

  • Panoptes Pharma — Panoptes is a privately held biotech company focused on developing small molecule based therapies for the treatment of severe eye diseases with high unmet medical need. Panoptes is located in the city center of Vienna, Austria.The development of Panoptes´ clinical candidate PP-001 focuses on a new treatment for autoimmune uveitis, a disease whichis one of the major causes of blindness. As a second indication, adenoviral conjunctivitis will be pursued, a disease for which to date, no treatment is available. Due to its unique mode of action, PP-001 has therapeutic potential for additional inflammatory and viral indications.Panoptes has an experienced team of development experts with a proven track record of developing and commercializing innovative products. The team is developing a focused portfolio of high-performance small molecule products, with its lead clinical candidate PP-001 in preclinical development.
Show all investments...

Forbion Capital Partners
VC Fund · Naarden, Noord-Holland, The Netherlands · 1 investments in Austria Biotech startups

Impacting the future of medicine.

Show more...

Investment focus

  • Industry: Biotechnology, Health Care, Medical
  • Stage:Series B, Series A, Series C
  • Geography: United States, United Kingdom, The Netherlands

Investor stats

  • Total investments: 187
  • Round size: Series A $16M–$176M; Series B $15M–$155M; Series C $19M–$113M
  • Lead/follow: 51% lead, 49% follow
  • Last fund: Likely actively investing — fund raised in 2024

Portfolio highlights

  • F2G — F2G is a biopharmaceutical company developing novel therapies for life-threatening fungal infections.
  • Noema Pharma — DRIVING BETTER OUTCOMES Advancing therapeutics designed to deliver superior clinical benefit across both orphan and broader neurology indications Who we are ...
  • Beacon Therapeutics — Beacon aids in restoring and improving the vision of patients with ophthalmic gene therapy. Find out more.
Show all investments...

Biotech VC funding in Austria at a glance

Stats across 129 deals from 153 investors.

153
investors
in Austria Biotech startups
129
deals
in Austria Biotech startups
$3.9M
median round
in Austria Biotech startups
47%
lead investors
lead at least one round
29%
Seed
most common funding stage

Access all 153 VC funds in Austria Biotech startups.

Open List

FAQ

Is Shizune data fresh/accurate?

Shizune has monitored hundreds of funding sources since 2020.

Our investor database is updated every day, so investor data is always fresh.

All metrics are calculated from confirmed public rounds, so the data is accurate.

Can I download investor list?

To download the Biotech VC Funds in Austria investor list, create a Shizune account. This investor list will be added to your saved investors and available for download in the export section.

You can also enrich the investor list with investor emails, phones, LinkedIns, and other contact data.

Can I access investor database?

To access all 153 VC funds investing in Austria Biotech startups and 48,091+ more investors, create a Shizune account.

Shizune has a database of 48,091 investors. Our investor database is fresh and updated daily.

The Shizune investor database has information on investor investment focus, investor contact data, and full investor portfolio since 2020.

You can enrich with email and download the data.

Does Shizune have investor emails and contacts?

Shizune enriches investors with contact data that includes: email, phones, LinkedIn, socials, website, and others.

To guarantee the highest discovery rate, we search across 20+ contact search tools.

To maximize delivery rate and reduce bounce rate, we validate emails.

You can enrich your investor list with Shizune. Download it too.

What is Shizune?

Shizune is a 48,091 investor database updated daily.

With Shizune you can:

  • browse the database
  • use smart matching
  • enrich with emails
  • download

All you need to find investors for your startup.

Who is Shizune for?

Shizune is built for startup founders by startup founders.

If you are looking for funding for your startup, try the Shizune database — we have investors for every stage, industry, and country.

Is Shizune free?

Shizune is free forever. You can search and browse investors for free.

Email search and export are paid features.

For full info, visit our pricing.

Who built Shizune?

Shizune is built by founders with the goal of helping all founders raise funding no matter where they are.

Contact 100 investors today

Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.

Find investors — It's Free!

More investor lists

Broader lists